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We ascertained a multi-generation Malaysian family with Joubert syndrome (JS). The presence of asymptomatic obligate carrier females
suggested an X-linked recessive inheritance pattern. Affected males presented with mental retardation accompanied by postaxial poly-
dactyly and retinitis pigmentosa. Brain MRIs showed the presence of a ‘‘molar tooth sign,’’ which classiﬁes this syndrome as classic JS
with retinal involvement. Linkage analysis showed linkage to Xpter-Xp22.2 and a maximum LOD score of 2.06 for marker DXS8022.
Mutation analysis revealed a frameshift mutation, p.K948NfsX8, in exon 21 of OFD1. In an isolated male with JS, a second frameshift
mutation, p.E923KfsX3, in the same exon was identiﬁed. OFD1 has previously been associated with oral-facial-digital type 1 (OFD1)
syndrome, a male-lethal X-linked dominant condition, and with X-linked recessive Simpson-Golabi-Behmel syndrome type 2
(SGBS2). In a yeast two-hybrid screen of a retinal cDNA library, we identiﬁed OFD1 as an interacting partner of the LCA5-encoded ciliary
protein lebercilin. We show that X-linked recessive mutations in OFD1 reduce, but do not eliminate, the interaction with lebercilin,
whereas X-linked dominant OFD1 mutations completely abolish binding to lebercilin. In addition, recessive mutations in OFD1 did
not affect the pericentriolar localization of the recombinant protein in hTERT-RPE1 cells, whereas this localization was lost for dominant
mutations. These ﬁndings offer a molecular explanation for the phenotypic spectrum observed for OFD1mutations; this spectrum now
includes OFD1 syndrome, SGBS2, and JS.Introduction
Joubert syndrome (JS [MIM 213300]) is characterized by a
speciﬁc mid-hindbrain malformation, hypotonia, cere-
bellar ataxia, and developmental delay. Oculomotor
apraxia and abnormalities in breathing patterns are
frequently part of this condition as well. The typical cere-
bellar and brainstemmalformations in JS result in a charac-
teristic neuroradiological hallmark known as the ‘‘molar
tooth sign.’’1 The molar tooth sign is not restricted to clas-
sical JS but has also been observed in disorders in which
more organ systems are affected. This group of syndromes
was termed Joubert syndrome and related disorders
(JSRDs)2, and a classiﬁcation into six subgroups has been
proposed.3 Apart from the classical form, JS can occur in
combination with progressive retinal degeneration,4 renal
abnormalities (nephronophthisis, NPHP [MIM 256100]),5
both retinal and renal involvement (cerebello-oculo-renal
syndromes, CORS [MIM 608091]),6 ocular colobomas
and liver abnormalities (COACH [MIM 216360]),7 and
both orofacial and digital signs (OFDVI [MIM 277170]).8
These additional features are characteristic of disorders
caused by primary cilium and/or basal-body dysfunction,9
indicating that the pathogenic mechanism in JSRDs prob-
ably involves defective cilium and/or basal-body function.The AmerSo far, nine autosomal JSRD loci have been mapped, and
causative genes have been identiﬁed for eight of these.3,10
All eight JSRD genes encode proteins that localize to cilia
or centrosomes, reiterating ciliary dysfunction as a key
factor in the molecular pathogenesis of JSRDs. The AHI1
(MIM 608894) gene is most frequently associated with
a combination of JS and retinopathy and encodes jouberin,
which physically interacts with the NPHP1-encoded neph-
rocystin-1 protein (MIM 607100).11–13 ARL13B (MIM
608922) encodes a small GTPase that belongs to the Arf/
Arl class of the Ras GTPase family.10 Animal ARL13B-null
models emphasize the ciliary importance of this gene in
that they reproduce cilia-relatedphenotypes such as disrup-
tion of neural-tube development, renal cysts, and overall
defective cilium morphology.14,15 The protein product en-
coded by the CC2D2A (MIM 612013) gene functions in
close association with the centrosomal protein CEP290.16
A nonsense mutation in the zebraﬁsh CC2D2A ortholog
(sentinel) results in the formation of pronephric cysts.16
The most recently identiﬁed JSRD gene is INPP5E, which
is the causative gene for the JBTS1 locus. The encoded
protein functions in phosphatidyl inositol signaling, link-
ing this pathway to the ciliopathies.17 The remaining four
JSRD genes have also been implicated in other overlapping
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TMEM67/MKS319 (MIM 609884), RPGRIP1L20,21 (MIM
610937), and also CC2D2A22 in Meckel syndrome (MIM
249000), and CEP290 (MIM 610142) in isolated Leber
congenital amaurosis (LCA [MIM204000]),23 Senior-Løken
syndrome (SLS, a combination of retinal degeneration and
NPHP [MIM266900]),24 andMeckel syndrome.25 The exact
biochemical pathway in which JSRD proteins play a role
remains unclear. However, experimental evidence is point-
ing to cilia-mediated Sonic hedgehog (Shh) signaling as
a likely candidate.15,20,26
In this study, we have identiﬁed mutations in exon 21 of
the OFD1 (MIM 311200) gene in two families with classical
JS, therebydeﬁningOFD1as the JBTS10 locus. Inone family,
patients also suffer from retinal pathology. To our knowl-
edge, this is the ﬁrst report of X-linked inheritance in JS
and of mutations in OFD1 downstream of exon 17. The
OFD1 gene has previously been associated with oral-facial-
digital type 1 (OFD1) syndrome (MIM 311200),27 which is
a male-lethal X-linked dominant condition involving mal-
formations of the face, oral cavity, and digits in affected
females. Budny and coworkers also described a single family
in which OFD1 was found to be mutated in Simpson-
Golabi-Behmel syndrome type 2 (SGBS2 [MIM 300209]).28
We show thatOFD1 directly binds to the ciliary protein leb-
ercilin, encoded by the LCA5 (MIM 611408) gene.29 Muta-
tions in LCA5 cause LCA, an inherited condition of very
early-onset childhoodblindness that is due to retinal degen-
eration and alsobelongs to the ciliopathy spectrum.Wealso
show thatX-linked recessivemutations inOFD1 reduce, but
do not eliminate, the interactionwith lebercilin and do not
affect ciliary localization in cell lines, whereas X-linked
dominant OFD1 mutations completely abolish binding
with lebercilin and disrupt ciliary localization as well. Our
ﬁndings offer a molecular explanation for the phenotypic
variability observed in OFD1-related disorders.
Material and Methods
Patients
In all patients from family W07-713, karyotypes at a resolution of
550 bands were normal, and expansions of the CGG repeat in the
50-untranslated region of FMR1 were excluded. In patient IV-10,
submicroscopic copy-number variations larger than 100 kb were
excluded by Affymetrix 250k SNP array analysis in which was
used as a restriction enzyme according to the manufacturer’s
protocols (Affymetrix, Santa Clara, CA, USA). Copy-number esti-
mates were made with the CNAG software package v. 2.0.30 In
addition, probands from 84 JS families in which only males were
affected were selected from a cohort of 250 families. All families
showed a molar tooth sign on MRI scan and had developmental
delay and ataxia. Known genes and loci for JSRD (AHI1, ARL13B,
CC2D2A, CEP290, NPHP1, RPGRIP1L, TMEM67, and chromo-
somal loci 9q34 and 11p11.2–q12.1) were excluded in most cases
by direct sequencing or segregation analysis. All DNA samples
were isolated from whole blood by the salting-out method as
described by Miller et al.31 Informed consent was obtained for
all patients, and research was approved by the respective local
ethics committees.466 The American Journal of Human Genetics 85, 465–481, OctobeX-Chromosomal Linkage Analysis
Polymorphic short-tandem-repeat markers on the X chromosome
were selected with an average distance of 10 cM between the
markers. Primers for amplifying these markers were designed
with the Primer3 program.32 An M13 tail was added to the 50
and 30 ends of the primers. Markers were ampliﬁed with an M13
forward primer labeled with one of the ﬂuorophores, FAM, VIC,
NED, or ROX, at the 50 end33 and an M13 reverse primer with
a 50-GTTTCTT-30 added to its 50 end so that tailing would be
reduced.34 Primer sequences are given in Table S1. PCR conditions
are available on request. Final PCR products weremixedwith eight
volumes of formamide and half a volume of Genescan 500(250)
LIZ size standard (Applied Biosystems, Foster City, CA, USA) and
analyzed with the ABI PRISM 3730 DNA analyzer (Applied Biosys-
tems). The results were evaluated by Genemapper (Applied Biosys-
tems). Two-point LOD scores were calculated by Superlink35, and
exclusion mapping was performed with GeneHunter PLUS v.
1.236; both programs are integrated in the computer program
easyLINKAGE.37 Inheritance model was set at recessive, and the
frequency of the disease allele was set at 0.001. Full penetrance
was assumed.
DNA Sequencing
Primers for ampliﬁcation of all exons of OFD1 (GenBank ID
NM_003588.3) were designed with the Primer3 program (Table
S1).32 Of the last exon, 374 nucleotides of the 30-untranslated
region were analyzed. PCR conditions are available on request.
The ABI PRISM BigDye Terminator Cycle Sequencing v. 2.0 Ready
Reaction Kit was used for sequencing PCR products with the same
forward and reverse primers as those used in the PCR, and the
products were analyzed with the ABI PRISM 3730 DNA analyzer
(Applied Biosystems).
Ampliﬁcation Refractory Mutation System
Ampliﬁcation Refractory Mutation System (ARMS) primers for
speciﬁc ampliﬁcation of either the wild-type or mutant allele
were designed with the Primer3 program (Table S1).32 The wild-
type or mutant alleles were ampliﬁed from 50 ng DNA by the
use of 10 U Taq polymerase (Invitrogen, Breda, The Netherlands)
in Taq buffer, 2.0 mM MgCl2, 0.25 mM dNTPs (Invitrogen, Breda,
The Netherlands), and 100 nM forward and reverse primers in
a total volume of 25 ml. PCR cycling conditions consisted of (1)
denaturation at 95C for 10 min, (2) 40 cycles of ampliﬁcation
by denaturation at 95C for 15 s, annealing at 58C for 15 s, and
elongation at 72C for 15 s, and (3) ﬁnal elongation at 72C for
10 min. PCR products were analyzed on a 1.5% agarose gel.
X Inactivation
Skewing of X inactivationwas investigated via analysis of the CGG
repeat in the promoter region of FMR1, for which the tested carrier
females had two different alleles. One microgram DNA from
carrier females and a male control was digested overnight at
37C with a combination of 40 U BamHI (Westburg, Leusden,
The Netherlands) and 20 U of the methylation-sensitive restric-
tion enzyme HhaI (Westburg), as well as 40 U BamHI alone as
a control, in NEB buffer 4 (Westburg) in a total volume of 50 ml.
Subsequently, complete digestion was ensured by redigestion of
the DNA for 4 hr at 37C via addition of half of the units of BamHI
and HhaI initially used in the reaction mixtures. The enzymes
were heat inactivated at 65C for 20 min. The CGG repeat was
ampliﬁed from 2.5 ml digestion mixture by 3 U Taq polymeraser 9, 2009
(Invitrogen, Breda, The Netherlands) in Pfx Amp buffer (Invitro-
gen, Breda, The Netherlands), 1.5 mM MgSO4, 0.25 mM dNTPs
(Invitrogen, Breda, The Netherlands), 43 PCR enhancer solution
(Invitrogen, Breda, The Netherlands), and 300 nM forward and
50-FAM-labeled reverse primers (Table S1) in a total volume of
20 ml. PCR cycling conditions consisted of (1) denaturation at
95C for 10 min, (2) 32 cycles of ampliﬁcation by denaturation
at 95C for 15 s, annealing at 64C for 2 min, and elongation at
75C for 2 min, and (3) ﬁnal elongation at 72C for 10 min. PCR
products were analyzed as described in the X-Chromosomal
Linkage Analysis section. Complete digestion of one of the two
alleles was conﬁrmed by the absence of a PCR product in the
BamHI- and HhaI-digested DNA of the hemizygous male control,
whereas in all other samples at least one allele was ampliﬁed.
Cell Culturing
Human B-lymphocytes were immortalized by transformationwith
Epstein-Barr virus according to established procedures.38 EBV-
LCLs from patients and controls were grown at 37C and 7.5%
CO2 in RPMI 1640medium (GIBCO, Breda, The Netherlands) con-
taining 10% (v/v) fetal calf serum (Sigma, Zwijndrecht, The
Netherlands), 1% 10 U/ml penicillin and 10 mg/ml streptomycin
(GIBCO), and 1% GlutaMAX (GIBCO). Twenty-four hours before
emetin treatment, cells were centrifuged at 200 3 g for 5 min at
room temperature and resuspended in fresh medium to a density
of 0.7 million cells per ml. Cells were treated with 100 mg/ml em-
etin for 10 hr. Subsequently, 5–10 million cells were harvested by
centrifugation at 200 3 g for 5 min at room temperature, washed
with PBS, and pelleted by centrifugation at 200 3 g for 5 min at
room temperature. Pellets for RNA isolation were snap frozen in
liquid nitrogen.
RNA Isolation and First-Strand Synthesis
Total RNAwas isolated with the NucleoSpin RNA II kit (Macherey-
Nagel, Du¨ren, Germany) according to the manufacturer’s pro-
tocol. For removing residual traces of genomic DNA, the RNA
was treated with DNase I (Invitrogen, Leek, The Netherlands)
while bound to the RNA-binding column. The integrity of the
RNA was assessed on 1.2% agarose gel, and the concentration
and purity were determined by optical densitometry. One micro-
gram of total RNA was transcribed into cDNA with the iScript
cDNA synthesis kit (Bio-Rad Laboratories, Hercules, CA, USA) ac-
cording to the manufacturer’s protocol. cDNA was puriﬁed with
the NucleoSpin extract II kit (Macherey-Nagel) according to the
manufacturer’s protocol.
Quantitative PCR
SYBR Green-based real-time quantitative PCR (QPCR) analysis was
performed on a 7500 Fast Real-Time PCR System (Applied Biosys-
tems) with Power SYBR Green PCR Master Mix (Applied Biosys-
tems) according to the manufacturer’s instructions. Primers were
developed by the Primer3 program32 (Table S1) and validated as
described before.39 PCR products encompassed at least one
exon-exon junction. GUSB was used as reference gene. QPCR
quantiﬁcations were performed in duplicate on the equivalent of
400 pg/ml input of total RNA in the ﬁrst-strand synthesis and
included a reverse-transcriptase control. Values for experimental
threshold cycles (Ct) were within the range of cDNA dilutions
used for validating the primers. The melt curves of all PCR prod-
ucts showed a single PCR product. All controls were negative.
Differences in the expression of a gene of interest between twoThe Amersamples were calculated by the comparative Ct or 2DDCt
method.40,41
DNA Constructs
Constructs encoding the full-length OFD1 variant of 1012 amino
acids (OFD1FL; NCBI Reference Sequence: NM_003611.2 [gene];
NP_003602.1 [protein]) were generated by PCR with an OFD1
cDNA clone that was kindly donated by Prof. Brunella Franco
(TIGEM Telethon Institute of Genetics and Medicine, Naples,
Italy). For this variant, the Coils2 program42 predicts six coiled-
coil domains. For the constructs encoding coiled-coil domains
two/three (fusion of coiled-coil domains two and three) and four
and coiled-coil domains ﬁve and six of OFD1, OFD1 cDNA IMAGE
clone (GenBank BC096344) (imaGenes, Berlin, Germany) was
used as a template in PCR. This clone contains an alternative splice
variant that lacks exon 10 and thus encodes a 972 amino acid
variant protein (OFD1Dex10) that lacks the corresponding amino
acids 313–353. For this splice variant, ﬁve coiled-coil domains
are predicted because coiled-coil domains two and three are fused
into one larger coiled-coil domain (coiled-coil domain two/three).
The OFD1 constructs encoding amino acids 240–1012 and amino
acids 356–1012 were generated by PCR on template DNA from the
corresponding clones that were identiﬁed in the yeast two-hybrid
assay, from which the ﬁrst clone includes exon 10. Expression
constructs were created with Gateway technology (Invitrogen,
Leek, The Netherlands) according to the manufacturer’s instruc-
tions. LCA5 constructs were generated as previously described.29
Constructs for OFD1 mutants were generated by site-directed
mutagenesis PCR. Primers are available upon request. The
sequence of all entry clones was veriﬁed by nucleotide sequencing.
Yeast Two-Hybrid Assays
The GAL4-based yeast two-hybrid system (HybriZAP, Stratagene,
La Jolla, USA) was used for identifying protein-interaction partners
of lebercilin. The region encompassing the ﬁrst 305 N-terminal
amino acids of lebercilin, fused to a DNA-binding domain
(GAL4-BD), was used as a bait for sreening a human oligo-dT
primed retinal cDNA library. The yeast strain PJ69-4A, which
carried the HIS3 (histidine), ADE2 (adenine), MEL1 (a-galactosi-
dase) and LacZ (b-galactosidase) reporter genes, was used as a
host. Interactions were analyzed by assessment of reporter gene
activation via growth on selective media (HIS3 and ADE2 reporter
genes), a-galactosidase colorimetric plate assays (MEL1 reporter
gene), and b-galactosidase colorimetric ﬁlter lift assays (LacZ
reporter gene). For analysis of the binding capacities of OFD1
mutant proteins to lebercilin, expression constructs encoding
amino acids 356–1012 of OFD1 as a GAL4-AD-fusion protein,
either wild-type or containing the p.K948fs, p.K923fs, p.I784fs,
p.E709fs, p.N630fs, or p.S586fs mutation, were cotransformed
with a construct encoding the ﬁrst two coiled-coil domains of leb-
ercilin fused to GAL4-BD (pBD-lebercilinCC1þ2) in PJ69-4a. As
a negative control, the empty pAD vector was cotransformed
with pBD-lebercilinCC1þ2. Protein interactions were evaluated on
the basis of growth on selective media and staining in a- and
b-galactosidase activity assays. The interactions of wild-type and
mutant OFD1 with wild-type lebercilin were semi-quantiﬁed
with a liquid b-galactosidase assay. Liquid cultures of PJ69-4a, co-
transformed with combinations of pAD-OFD1 and pBD-lebercilin
(n ¼ 4 for each combination), were grown for 24 hr at 30C in SD
medium lacking leucine and tryptophan. Subsequently, the
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of 600 nm for data normalization. Cell lysis and colorimetric reac-
tions were performed with the Yeast b-galactosidase assay kit
(Pierce Biotechnology, Rockford, IL, USA) according to the manu-
facturer’s instructions. b-galactosidase activity was determined
from absorbance at a wavelength of 420 nm. For the calculation
of relative remaining reporter gene activity, values were corrected
for background activity in the assay.
Colocalization in hTERT-RPE1 Cells
hTERT-RPE1 cells (kindly provided by Prof. Uwe Wolfrum, Jo-
hannes-Gutenberg Universita¨t, Mainz, Germany) were cultured
as previously described.16 This is a human retinal pigment epithe-
lial (RPE) cell line that is immortalized by stable expression of
human telomerase reverse transcriptase (hTERT) (Clontech, Saint-
Germain-en-Laye, France). Cells were seeded on coverslips and
were serum starved for 24 hr prior to transfection so that primary
cilium formation would be induced. Subsequently, Effectene
(QIAGEN, Venlo, The Netherlands) was used for transfecting cells.
Single constructs encoding either wild-type or mutant OFD1 fused
to enhanced cyan ﬂuorescent protein (eCFP) or a combination of
constructs encoding eCFP-OFD1 and constructs encoding full-
length lebercilin fused to monomeric red ﬂuorescent protein
(mRFP) were transfected. After 24 hr, cells were ﬁxed in icecold
methanol for 10 min, treated with 1% Triton X-100 in phos-
phate-buffered saline (PBS) for 5 min, and blocked in 2% bovine
serum albumine in PBS for 20 min. Incubation with the primary
antibody GT335 (mouse monoclonal antibody, kindly provided
byCarsten Janke,CNRSCentre de Recherches en BiochimieMacro-
mole´culaire, Montpellier, France) was performed for 1 hr. After
being washed in PBS, coverslips were stainedwith goat-anti-mouse
Alexa 568 (Invitrogen, Leek, The Netherlands) for 45 min. Cover-
slips were washed again with PBS and brieﬂywithmQbefore being
mounted inVectashield containingDAPI (Vector Laboratories, Bur-
lingame, CA, USA). The localization of constructs was analyzed
with a Zeiss Axio Imager Z1 ﬂuorescence microscope equipped
with a 633 objective lens.
GST Pull-Down Assay
Both OFD1 splice variants and OFD1 fragments (amino acids 240–
1012 and amino acids 356–1012) were cloned into pDEST15
(Gateway cloning system, Invitrogen, Karlsruhe, Germany). For
the creation of GST-fusion proteins, BL21-DE3 cells were trans-
formed with pDEST15 constructs. Cells were induced overnight
with 0.5 mM IPTG at 30C and subsequently lysed in STE buffer
(10mMTris-HCl [pH 8.0], 1mMEDTA, and 150mMNaCl) supple-
mented with 10 mg/ml Lysozyme, 0.5% Sarkosyl, 1% Triton X-
100, and complete protease inhibitor cocktail (Roche Diagnostics,
Mannheim, Germany). Lysates were incubated with glutathione-
sepharose 4B beads (Amersham Biosciences, Freiburg, Germany).
After incubation, beads were washed with STE and TBSTD (TBS
with 1% Triton X-100 and 2 mMDTT). The amount of GST-fusion
proteins bound to the beads was veriﬁed on a NuPAGE Novex 4%–
12% Bis-Tris SDS–PAGE gel by staining with SimplyBlue SafeStain
(Invitrogen, Leek, The Netherlands). Beads with boundGST-fusion
proteins were incubated for 2.5 hr at 4C with lysates of COS-1
cells expressing 3xFLAG-tagged full-length human lebercilin. After
incubation, beads with bound protein complexes were washed in
lysis buffer, and this was followed by a washing step with Complex
Washing Buffer (50 mM Tris-HCl [pH 7.5], 100 mM NaCl, 2 mM
MgCl2, 2 mM CaCl2, 1% TritonX-100, and 2 mM DTT). Then
beads were taken up in 43 NuPage Sample Buffer and heated for
10 min at 70C. Beads were precipitated by centrifugation, and468 The American Journal of Human Genetics 85, 465–481, Octobesupernatant was loaded on a NuPAGE Novex 4%–12% Bis-Tris
SDS–PAGE gel. The presence of 3xFLAG-lebercilin in complex
with GST-OFD1 was assessed by immunoblotting, followed by
staining with a monoclonal mouse a-FLAG primary antibody
(Sigma-Aldrich, Zwijndrecht, The Netherlands) and goat-anti
mouse coupled to IRDye800 (Rockland Immunochemicals, Gil-
bertsville, PA, USA) as a secondary antibody. Fluorescence was
analyzed on a Li-Cor Odyssey 2.1 infrared scanner.
Coimmunoprecipitation
HA-lebercilin (full-length) and 3xFLAG-OFD1 (both splice variants
and fragments encompassing amino acids 240–1012 and amino
acids 356–1012) were coexpressed in HEK293T cells. As a negative
control, HA-lebercilin was coexpressed with the functionally unre-
lated 3xFLAG-LRRK2 (Leucine-Rich Repeat Kinase2) protein. As
a positive control, the previously described interaction between
nephrocystin4 and RPGRIP1 was used.43 After 48 hr of expression,
cells were lysed on ice in lysis buffer (50 mM Tris–HCL [pH 7.5],
150 mM NaCl, 0.5% Triton X-100) supplemented with complete
protease inhibitor cocktail. Lysates were incubated with anti-HA
afﬁnity matrix (Roche, Woerden, The Netherlands), or with anti-
FLAG M2-agarose from mouse (Sigma-Aldrich, Zwijndrecht, The
Netherlands), for 5 hr at 4C. After incubation, beads with bound
protein complexes were washed in lysis buffer. Then beads were
taken up in 43 NuPage Sample Buffer and heated for 10 min at
70C. Beads were precipitated by centrifugation, and supernatant
was run on a NuPAGE Novex 4%–12% Bis-Tris SDS-PAGE gel. The
interaction of 3xFLAG-OFD1 with HA-lebercilin was assessed by
immunoblotting, followed by staining with either monoclonal
mouse a-FLAG or monoclonal mouse a-HA (Sigma-Aldrich, Zwijn-
drecht, The Netherlands) as a primary antibody and goat-anti
mouse RDye800 as a secondary antibody. Fluorescence was
analyzed on a Li-Cor Odyssey 2.1 infrared scanner.
Immunoﬂuorescence Labeling of Rat Retinas
Unﬁxed eyes of 20-day-old (p20) Wistar rats were harvested and
frozen in melting isopentane. Seven micrometer cryosections
were cut and treated with 0.01% Tween in PBS and subsequently
blocked in blocking buffer (0.1% ovalbumin and 0.5% ﬁsh gelatin
in PBS). Then the cryosections were incubated overnight with
primary antibodies diluted in blocking buffer, either with afﬁnity-
puriﬁed a-lebercilin rabbit serum29 in combination with a mouse
a-centrin monoclonal antibody (kindly provided by Prof. Uwe
Wolfrum, Johannes-Gutenberg Universita¨t, Mainz, Germany) or
with afﬁnity-puriﬁed a-OFD1 rabbit serum (kindly provided by
Prof. E. Nigg, Max-Planck Institut fu¨r Biochemie, Martinsried,
Germany) in combination with a mouse a-centrin monoclonal
antibody. Secondary antibodieswere also diluted inblockingbuffer
and incubated in a dark environment for 1 hr. Prolong Gold Anti-
fade (Molecular Probes, Leiden, The Netherlands) was used for
embedding the sections. Pictures were made with an Axioskop2
Mot plus ﬂuorescence microscope (Zeiss, Oberkochen, Germany),
which was equipped with an AxioCam MRC5 camera (Zeiss).
Images were processed with Axiovision 4.3 (Zeiss) and Adobe Pho-
toshop (Adobe Systems, San Jose, CA, USA). Procedures were in
accordancewith theethical standardsof the responsible committee
on animal experimentation.
Expression Analysis of OFD1 Isoforms
Total RNA from different human tissues was ordered from Strata-
gene (La Jolla, CA, USA) except for retina total RNA, which wasr 9, 2009
purchased from Clontech (Saint-Germain-en-Laye, France). cDNA
synthesis was performed as described above. PCR primers posi-
tioned on exon 8 and on the boundary of exons 13 and 14 are
given in Table S1. PCR was stopped at cycles 25, 30, and 35.
Speciﬁc PCR conditions are available on request. So that OFD1
protein isoform expression in bovine retina could be investigated,
retinal extracts were made from fresh bovine retinas, obtained
from the local slaughterhouse. Retinas were lysed by soniﬁcation
for 1 min in lysisbuffer (50 mM Tris-HCl [pH 7.4], 150 mM
NaCl, 0,5% Nonidet-P40, and 1 mMNatrium-orthovanadate) sup-
plemented with protease inhibitors (Roche Diagnostics, Man-
nheim, Germany). Retinal extract was run on a NuPAGE Novex
4%–12% Bis-Tris SDS–PAGE gel. OFD1 protein expression was
analyzed by immunoblotting, followed by staining with rabbit
a-OFD1 polyclonal antibody and goat-anti mouse RDye800 (Rock-
land Immunochemicals, Gilbertsville, PA, USA) as a secondary
antibody. Fluorescence was analyzed on a Li-Cor Odyssey 2.1
infrared scanner.
Results
Clinical Descriptions
Family W07-713 consists of eight males with severe to
profound mental retardation (Figure 1A). Family members
IV-5, IV-6, and IV-10 also have postaxial polydactyly in all
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Figure 1. Pedigree and Mutation Anal-
ysis of Family W07-713
(A) Pedigree of family W07-713. Indicated
are the four discerning clinical features of
the patients in the family: mental retarda-
tion, postaxial polydactyly, juvenile RP,
and the presence of a molar tooth sign
on an MRI scan. Indicated in gray are the
patients who were not investigated by
MRI.
(B) Chromatograms showing the wild-type
sequence in family member III-7 (up) and
the c.2841_2847 delAAAAGAC deletion
in patient IV-10 (down) in exon 21 of
OFD1.
(C) Chromatograms showing the wild-
type sequence in the healthy father (up)
and the c.2767 delG mutation in patient
UW87 (down) in exon 21 of OFD1.
four limbs. The deceased males IV-2
and IV-4 shared this feature. Retinitis
pigmentosa (RP) was noticed in
family members III-9, III-10, and IV-
10. All patients had recurrent infec-
tions, of which family members
IV-2, IV-3, and IV-4 died. None of
the patients were obese, and all had
normal genitalia. No abnormalities
were noticed by renal ultrasound
scanning. None of the female family
members had any symptoms similar
to those of the male patients, indi-
cating that the inheritance pattern is
most likely X-linked recessive.
Patients IV-10 and III-9 were investigated in more detail.
Patient IV-10 was born at term by a lower-segment
cesarean section. His birth weight was 3050 g (50th percen-
tile), his length was 48.5 cm (25th percentile), and his head
circumference was 34.5 cm (25th percentile). Soon after
birth, he presented with stridor and intermittent cyanosis
and was thought to have central apnea. He also had
feeding problems that required tube feeding. A delay in
his development was apparent: he was not able to sit or
stand at the age of 3.5 years, although he could roll over
at 6 months of age. All growth parameters were below 2
standard deviations (SD). The patient had apparent post-
axial polydactyly of all four limbs, although central poly-
dactyly could not be excluded (Figure 2B). He presented
with mild hirsutism, had low-set ears, a broad nasal bridge,
prominent philtrum and maxillary arch, and full lips
(Figure 2A). Fingers and nails were normal, as were his
genitalia. He could not speak, was unable to grasp or reach
out for objects, and responded minimally to eye contact or
sounds. He was easily irritated and had frequent temper
tantrums during which he bit his tongue and lips. In addi-
tion, every two weeks he had unexplained fevers that
could be treated by antipyretics. There were no serious
infections that required hospital admission. The patientThe American Journal of Human Genetics 85, 465–481, October 9, 2009 469
Figure 2. Clinical Phenotype of Family
W07-713 and Isolated Patient UW87
(A–D) Shown are photographs of (A) the
face and (B) hands and foot, as well as (C
and D) brain MRI images, of patient
IV-10 at the age of 1 year. Note the low-
set ears, broad nasal bridge, prominent
philtrum and maxillary arch, full lips,
and postaxial polydactyly of all four limbs,
although central polydactyly can not be
excluded. On an axial T1-weighted brain
MRI, a clear molar tooth sign is visible.
(E–H) Shown for patient III-9, who was
34 yrs-old at the time of examination, are
(E) frontal and (F) side views of the face
and (G and H) brain MRI images. This
patient also has low-set ears, a broad nasal
bridge, a prominent philtrum and maxil-
lary arch, and full lips. No polydactyly
was present. An axial T1-weighted MRI
image showed a molar tooth sign.
(I–L) For patient UW87, who was exam-
ined at the age of 12 yrs, (I) frontal and
(J) side views of the face, as well as (K and
L) axial T1-weighted brain MRI images,
are shown. This patient showed macroce-
phaly and obesity. Polydactyly was re-
ported, but the sixth ﬁnger was removed
shortly after birth. A molar tooth sign
was evident from MRI images.had retinal degeneration pointing to juvenile RP. He also
had conductive hearing impairment that might be ex-
plained by the bilateral middle-ear effusion. Routine blood
analysis showed no aberrations in hematologic values, liver
function, or renal function; a renal sonography and echo-
cardiogram were also normal. A brain MRI showed a molar
tooth sign, hypoplasia of the cerebellar vermis, thickening
of the superior cerebellar peduncles, and deep interpedun-
cular fossa (Figure 2C). Furthermore, patient IV-10 had
a small pons and prominent medulla (Figure 2D).
Patient III-9 had severe mental retardation and was
unable to care for himself. Breathing problems in early
childhood were not noticed. He had low-set ears, a broad
nasal bridge, a prominent philtrum and maxillary arch,
and full lips, but no postaxial polydactyly (Figures 2E and
2F). He had recurrent respiratory infections during early
childhood. By the age of 34, his vision was deteriorated
to such an extent that he could only see shadows. Renal
sonography showed no aberrations, but from the age of
31 onward, he had hypertension. AnMRI scan of the brain
also showed amolar tooth sign (Figure 2G), although it was
more subtle than that of patient IV-10. Hypoplasia of the
cerebellar vermis and thick superior cerebellar peduncles,
as well as a cavum velum interpositum and mild volume
loss in the cerebral and cerebellar hemispheres, were seen
on a brain MRI, suggesting atrophy. The pons and medulla
appeared normal in this patient (Figure 2H).
Patient UW87 is part of a cohort of 84 male JS patients
who were screened for mutations after the identiﬁcation
of OFD1 as a JS gene. He was born to healthy nonconsan-470 The American Journal of Human Genetics 85, 465–481, Octoberguineous parents at 41 weeks gestation by cesarean section
for failure to progress, after a pregnancy complicated by
polyhydramnios. His birth weight was 4090 g, his length
was 53 cm (90th percentile), and his head circumference
was 35.5 cm (50th percentile). As a newborn, he was noted
to have tongue thrusting, distinctive craniofacial features,
and postaxial polydactyly of both hands and the left foot.
BrainMRIs performed at 3 weeks and 8 years of age demon-
strated a molar tooth sign (Figure 2K), a small occipital en-
cephalocele, and shortening of the corpus callosum
(Figure 2L). A history of repeated middle-ear infections in
early childhood required pressure equalization tubes, but
no serious infections were reported. A gastrostomy tube
was required because of feeding difﬁculties. On evaluation
at 12 years of age, severe intellectual disability, ambulation
difﬁculties, and hyperphagia with obesity were noted. He
used a wheelchair and walker for mobility, lacked discern-
able words, and was not toilet trained. On examination, he
had macrocephaly (head circumference 58.1 cm, >97th
percentile) and generalized obesity (97.7 kg, >97th percen-
tile), and his height could not be measured because of
combativeness and stooping (Figures 2I and 2J). He had
deep-set eyes, narrowed palpebral ﬁssures, a left-sided pre-
auricular pit, a ﬂattened midface, a midline upper-lip
notch, a deep midline groove of the tongue, a prominent
jaw, and redundant neck tissue. His extremities were
notable for relative brachydactyly, fetal ﬁnger pads, small
feet (US size 5 shoes), and lateral deviation and contrac-
tures at the knees. He had normal male genitalia and
Tanner stage 3-4 pubic hair. On neurological examination,9, 2009
he had mild peripheral hypotonia, reduced tendon jerks,
and mild dysmetria. Renal ultrasounds were normal, and
serum transaminases were mildly elevated on at least two
occasions. Ophthalmological examination was chal-
lenging, and apparent optic nerve atrophy was noted,
but no pigment changes were seen.
Linkage Analysis
We performed linkage analysis with 16 markers on the X
chromosome (Table 1). A maximum two-point LOD score
of 2.07 was obtained for marker DXS8022. It was possible
to exclude the remainder of the X chromosome from
linkage (LOD score <2). The interval is delimited by the
pseudoautosomal region on the telomeric side and by
DXS8036 on the centromeric side (Figure 1A). The 14 Mb
interval contains 66 annotated genes (NCBI Map Viewer
build 36.3), four of which, OFD1, NLGN4X, HCCS, and
PRPS2, are included in the ciliary proteome database and
thus might encode ciliary proteins.44 To our knowledge,
ciliary localization has only been experimentally proven
for the protein encoded by OFD1. Mutations in NLGN4X
are involved in autism and/or mental retardation (MIM
300495), and those in HCCS are involved in microphthal-
mia and linear skin defects (MIM 309801). Mutations in
OFD1 cause OFD1 syndrome and SGBS2. Mutations in
PRPS2 have not been reported.
OFD1 Is Mutated in Joubert Syndrome Patients
Because patients in the families investigated in this report
have features in common with OFD1 and SGBS2 patients,
Table 1. Two-Point LOD Scores for 16 X-Chromosomal Markers
Marker
Position
(cM) q ¼ 0 q ¼ 0.05 q ¼ 0.1 q ¼ 0.15 q ¼ 0.2
DXS8022 27.46 2.07* 1.88 1.68 1.47 1.25
DXS8036 30.31 5.63 0.34 0.49 0.51 0.47
DXS8099 42.25 5.65 0.33 0.48 0.50 0.46
DXS8047 43.05 5.63 0.34 0.49 0.51 0.47
DXS1214 46.21 8.40 0.66 0.21 0.02 0.07
DXS9907 48.55 8.45 1.25 0.75 0.50 0.35
DXS8090 56.02 5.98 0.03 0.20 0.25 0.25
DXS8012 64.51 5.96 1.19 0.65 0.36 0.18
DXS1003 72.39 5.94 1.18 0.64 0.36 0.18
DXS1204 78.52 5.61 0.88 0.37 0.12 0.02
DXS8092 86.45 5.60 0.65 0.17 0.06 0.17
DXS990 94.92 5.59 0.66 0.18 0.05 0.17
DXS8096 103.56 19.43 2.15 1.34 0.89 0.61
DXS1212 123.88 10.38 3.20 2.10 1.51 1.13
DXS8043 160.62 14.06 3.46 2.30 1.64 1.18
DXS8103 178.77 5.96 1.19 0.65 0.36 0.18
Significant LOD scores are marked with an asterisk. The genetic distances are
given according to the Marshfield map.57The Amerwe ﬁrst analyzed OFD1 in family member III-10. Mutation
analysis of all exons and splice sites ofOFD1 showed a dele-
tion of seven base pairs in exon 21: c.2841_2847 delAAAA
GAC (p.K948NfsX8) (Figure 1B). The deletion cosegregated
with the disease in the family as shown by direct DNA
sequencing in all family members and was not present in
190 male controls as shown by ARMS, nor in an additional
250 control chromosomes as shown by direct sequencing
(data not shown). Analysis of all OFD1 exons and splice
sites in 65 males with JS and of exons 16–23 in 19 addi-
tional male JS patients revealed one de novo mutation,
c.2767 delG (p.E923KfsX3), in exon 21 in patient UW87
(Figure 1C). This mutation was not present in 250 control
chromosomes as shown by direct sequencing (data not
shown) and supports the involvement of OFD1 in JS.
Because OFD1 escapes X inactivation45, X inactivation
should not be skewed in obligate carrier females. Indeed,
in carrier females III-2, III-4, and III-8, there is no preferen-
tial expression of either X chromosome (data not shown).
The deletion causes a frameshift in the OFD1 protein, re-
sulting in a premature termination codon eight amino
acids after I947. This termination codon should, in theory,
give rise to nonsense-mediated decay of the OFD1 mRNA.
QPCR analysis of OFD1 mRNA levels in EBV-LCLs from
family member III-9 and isolated patient UW87 showed
that 30% and 58%, respectively, of OFD1 expression re-
mained (Figure S1).
OFD1 Interacts with Lebercilin
OFD1 was identiﬁed as an interacting partner of the LCA5-
encoded protein lebercilin by a GAL4-based yeast two-
hybrid screen of a retinal cDNA library; the ﬁrst 305
N-terminal amino acids of lebercilin were used as a bait.
Two independent prey clones that encoded largely over-
lapping OFD1 fragments, amino acid residues 356–1012
and 240–1012, respectively, were identiﬁed. The fragments
interacting with lebercilin cover ﬁve of the six predicted
coiled-coil regions of OFD1 and stretch as far as the C
terminus (Figure 3A).46 Apart from the full-length OFD1
protein of 1012 amino acids (OFD1FL), there exists an alter-
native splice variant that lacks exon 10 and thus encodes
a protein (OFD1Dex10) lacking the corresponding 40 amino
acids encoded by this exon. Both OFD1 splice variants
appear to be of similar biological importance because
mRNA of both isoforms is equally expressed in several
human tissues and protein expression of both isoforms is
detected in bovine retinal extracts (Figure S2).
The lebercilin-OFD1 interactionwas conﬁrmed in a dedi-
cated yeast two-hybrid assay, in which both OFD1 frag-
ments (amino acid residues 356–1012 and 240–1012)
were coexpressed with full-length lebercilin. In order to
determine which coiled-coil regions of lebercilin are
responsible for OFD1 binding, we coexpressed different
combinations of lebercilin deletion constructs fused to
GAL4-BD with OFD1 fused to GAL4-AD in yeast, and we
assessed protein-protein interactions by monitoring
reporter gene activation (Figure 3A). The region containingican Journal of Human Genetics 85, 465–481, October 9, 2009 471
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Figure 3. OFD1 Interaction with Lebercilin
(A) OFD1 and lebercilin protein structures. The protein domains of the two OFD1 isoforms (OFD1FL and OFD1Dex10) and the OFD1 frag-
ments identiﬁed in the yeast two-hybrid screen are depicted, alongwith the protein domains of the lebercilin fragments expressed by the
deletion constructs that were tested for interaction.
(B) Yeast two-hybrid assays conﬁrmed binding of both OFD1 fragments, spanning amino acid residues 240–1012 and 356–1012, to full-
length lebercilin and the regioncontaining theﬁrst twopredicted coiled-coil domainsof lebercilin.OFD1 fragments containingcoiled-coil
domains two/three and four (amino acids 240–614 Dex10 [Daa313–353]) and coiled-coil domains ﬁve and six (amino acids 615–1012)
both interacted with full-length lebercilin and with the lebercilin fragment spanning amino acids 96–305, although the OFD1 fragment
containing coiled-coil domains two/three and four showed the highest afﬁnity. NA ¼ not analyzed; activation of the HIS3 and ADE2
reporter genes is qualitatively indicated by – (no growth on selectivemedia),þ/ (slow growth),þ (growth), orþþ (fast growth). The acti-
vation of theMEL1 (a-galactosidase activity) and the LacZ (b-galactosidase activity) reporter genes was in line with these results.472 The American Journal of Human Genetics 85, 465–481, October 9, 2009
the ﬁrst two coiled-coil domains of lebercilin (amino acid
residues 96–305, lebercilinCC1þ2) was identiﬁed as the
region with the highest OFD1 binding afﬁnity on the basis
of growth on selective media (activation of the HIS3 and
ADE2 reporters) and both a- and b-galactosidase activity
assays (Figure 3B). Similarly, OFD1 constructs encoding
coiled-coil domains two/three and four (amino acid resi-
dues 240–614 Dex10 [Daa313–353]) and coiled-coil
domains ﬁve and six (amino acid residues 615–1012)
were cloned from the OFD1Dex10 splice variant and tested
in a yeast two-hybrid assay (Figure 3A). Both regions of
OFD1 interacted with full-length lebercilin and with
amino acid residues 96–305 of lebercilin, but the binding
afﬁnity of coiled-coil domains two/three and four was
the highest (Figure 3B).
To validate the interaction between OFD1 and lebercilin,
we performed both GST pull-down and coimmunoprecipi-
tation assays. For the GST pull-down assay, both OFD1
variants (OFD1FL and OFD1Dex10), as well as the OFD1
fragments encompassing amino acids 240–1012
(OFD1aa240–1012) and 356–1012 (OFD1aa356–1012), were ex-
pressed as GST fusion proteins. All of these fragments
pulled down 3xFLAG-tagged full-length lebercilin from
COS-1 cell lysates (Figure 3C). In a control experiment
for speciﬁcity, unfused GST failed to pull down lebercilin
completely. To assess coimmunoprecipitation of OFD1
with lebercilin, we expressed HA-tagged lebercilin in
HEK293T cells together with the previously mentioned
OFD1 splice variants and fragments fused to a 3xFLAG-
tag. Upon immunoprecipitation of HA-lebercilin via anti-
HA beads, all 3xFLAG-OFD1 protein variants and frag-
ments coprecipitated (Figure 3D), although 3xFLAG-
OFD1Dex10 and 3xFLAG-OFD1aa240–1012 apparently copre-
cipitated less efﬁciently. The unrelated 3xFLAG-LRRK2
protein did not coprecipitate with HA-lebercilin; this
ﬁnding conﬁrmed speciﬁcity of the interaction between
lebercilin and OFD1 in the coimmunoprecipitation assay.
(Figure 3D). The coimmunoprecipitation experiment was
repeated with anti-FLAG beads in the immunoprecipita-
tion step. Again, coprecipitation of HA-lebercilin with
3xFLAG-OFD1 was observed. In this experimental set up,
3xFLAG-OFD1Dex10 and 3xFLAG-OFD1aa240–1012 bound
more efﬁciently; therefore, no conclusions on the relative
interaction efﬁciencies of the OFD1 fragments can be
drawn. To provide additional evidence for the OFD1-leber-
cilin interaction, we performed coimmunoprecipitation
assays in which the 3xFLAG and HA tags for OFD1 and leb-The Amerercilin were swapped. These experiments corroborated our
previous ﬁndings: again, coprecipitation of both proteins
could be observed (Figure S3).
Colocalization of OFD1 with Lebercilin
To provide in vivo support for the in vitro OFD1-lebercilin
interaction, we performed colocalization experiments in
ciliated hTERT-RPE1 cells and rat retina. GFP-OFD1 was
previously reported to be targeted to the centrosome
because it colocalized with the centrosomal marker
g-tubulin inHEK293 cells.46 Lebercilin localizes at the basal
body and primary cilium, but association with micro-
tubules has been observed as well.29 We found that upon
expression in hTERT-RPE1 cells, eCFP-OFD1FL and eCFP-
OFD1Dex10 showed a characteristic pericentriolar localiza-
tion concentrated around the basal body, which was
costained with the basal-body and cilium marker a-gluta-
mylated tubulin (GT335) (Figures 4A–4F). A similar locali-
zation has also been reported for CEP290 and PCM-1.47,48
This characteristic localization did not depend on the pres-
ence of exon 10 in theOFD1 construct: both splice variants
showed similar pericentriolar localization. When we coex-
pressed eCFP-OFD1Dex10 and mRFP-lebercilin in hTERT-
RPE1 cells, partial colocalization was observed (Figures
4G–4I). In rat photoreceptor cells, both OFD1 and leberci-
lin localize to the connecting cilium region, which is essen-
tially the ciliary transition zone (Figures 4J–4O). This
speciﬁc connecting cilium localization was evident from
costaining of both proteins with the ciliummarker centrin.
OFD1 Mutations Reduce Interaction with Lebercilin
and Change Ciliary Localization
To explain the phenotypic spectrum observed for OFD1
mutations, we tested whether six OFD1 mutations,
p.K948fs and p.E923fs (XL-JS; this report), p.I784fs
(OFD149), p.E709fs (SGBS228), p.N630fs (OFD150), and
p.S586fs (OFD127), affect interaction with lebercilin and/
or subcellular localization. In a yeast two-hybrid interac-
tion assay, the p.I784fs, p.N630fs, and p.S586fs mutations
completely disrupted interaction of OFD1 with the frag-
ment containing the predicted coiled-coil domains 1 and
2 of lebercilin, as evidenced by the fact that none of the
reporter genes for interaction were activated (Figure 5A).
For the p.E923fs mutant, yeast growth was signiﬁcantly
reduced in comparison to wild-type OFD1 under condi-
tions selecting for interaction, indicating a reduced
binding afﬁnity. The p.K948fs mutation only slightly(C) Both GST-OFD1 Dex10 and the GST-fused OFD1 fragments spanning amino acid residues 240–1012 and 356–1012 (10% input of the
assay shown in panel 3) efﬁciently pulled down 3xFLAG-tagged full-length lebercilin (10% input shown in panel 1; pull-down assay
shown in panel 2). Unfused GST failed to pull down lebercilin at all, whereas, in a positive control experiment, GST-nephrocystin-4-I
pulled down RPGRIP1C2-end.
(D) The immunoblot (panel 4) shows that 3xFLAG-tagged OFD1 fragments coimmunoprecipitated withHA-lebercilin, whereas the unre-
lated 3xFLAG-LRRK2 protein did not. Five percent of the cell lysate inputs used in the assays are shown in panels 1 and 2, and the HA
immunoprecipitates are shown in panel 3. As a positive control, 3xFLAG-RPGRIP1C2-end coimmunoprecipitated with HA-fused nephro-
cystin-4-I.
(E) When anti-FLAG immunoprecipitation was performed, HA-lebercilin coimmunoprecipitated with all 3xFLAG-tagged OFD1 frag-
ments, as shown in the immunoblot in panel 4. Panels 1 and 2 show ﬁve percent of the cell lysate inputs used in the assays, and panel
3 depicts FLAG immunoprecipitates.ican Journal of Human Genetics 85, 465–481, October 9, 2009 473
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Figure 4. OFD1 and Lebercilin Colocalization in hTERT-RPE1 Cells and Rat Retina
(A–C) Colocalization of eCFP-OFD1Dex10 (A, green) and the basal-body and ciliummarker GT335 (B, red), a mouse monoclonal antibody
against polyglutamylated tubulin. eCFP-OFD1Dex10 localizes to the pericentriolar region. (C) is overlay of (A) and (B).
(D–F) eCFP-OFD1FL (D, green) also shows similar pericentriolar localization, as seen from costaining with GT335 (E, red). (F) is an overlay
of (D) and (E).
(G–I) Colocalization of eCFP-OFD1Dex10 (G, green) andmRFP-lebercilin (H, red). Colocalization is observed at the basal-body region. (I) is
an overlay of (G) and (H).
(J–O) Colocalization of lebercilin (J, green) andOFD1 (M, green) with centrin (K andN, red), a marker of the connecting cilium region, in
rat photoreceptor cells. (L) and (O) are overlays. In all pictures, nuclei are stained with DAPI (blue). Abbreviations are as follows: RPE,
retinal pigment epithelium; OS, outer segment; CC, connecting cilium; IS, inner segment; ONL. outer nuclear layer; OPL, outer plexi-
form layer; and INL, inner nuclear layer.reduced yeast growth, whereas the p.E709fs mutation did
not apparently affect yeast growth. For the mutants that
retained interaction in the yeast two-hybrid assay, we
also assessed the effects on lebercilin binding in a semi-
quantitative liquid b-galactosidase assay, demonstrating
activation of the LacZ reporter gene (Figure 5B). This assay
showed that the p.E709fs mutation moderately decreased
OFD1 binding to lebercilin (60% residual reporter gene
activity compared to that of wild-type OFD1). The474 The American Journal of Human Genetics 85, 465–481, Octoberp.K948fs and p.E923fs mutations more strongly decreased
OFD1 binding to lebercilin (24% and 18% residual reporter
gene activity, respectively).
We also investigated to what extent OFD1 mutations
inﬂuenced cellular localization of the encoded eCFP-fusion
protein. In hTERT-RPE1 cells, the JS-associated p.K948fs
and p.E923fs mutants (Figures 6A–6F) and the SGBS2-
associated p.E709fs mutant (Figures 6J–6L) retained peri-
centriolar localization, comparable to that of wild-type9, 2009
AB
Figure 5. Effect of OFD1 Mutations on Interaction with Lebercilin
(A) Interaction of wild-type (WT) OFD1 andOFD1mutants with lebercilin in the yeast two-hybrid assay. Expression constructs encoding
the amino acid fragment 356–1012 of OFD1 as GAL4-AD-fusion protein, either wild-type or containing the p.K948fs, p.K923fs, p.I784fs,
p.E709fs, p.N630fs, or p.S586fs mutation, were cotransformed with pBD-lebercilinCC1þ2 constructs in PJ694a. As a negative control, the
empty pAD vector was cotransformed with pBD-lebercilinCC1þ2. Cotransformation of GAL4-AD- and GAL4-BD-expressing plasmids
from the Hybrizap kit was used as positive control. Media lacking the amino acids Leu and Trp selected for cotransformants (LWpanel).
Additional omission of His and Ade from the media selected for activation of associated HIS3 and ADE2 reporter genes (LWHA panel).
Colonies growing under this selectionwere transferred to a ﬁlter for a b-galactosidase assay (LWHA b-galactosidase panel). Blue staining
indicates b-galactosidase activity by activation of the LacZ reporter gene. The interaction of lebercilinCC1þ2 with wild-type OFD1, as well
as with the OFD1 mutants p.K948fs, p.E923fs, and p.E709fs, was detected by growth on LWHA-selective media and a positive LacZ
assay. The OFD1 proteins containing the p.I784fs, p.N630fs, and p.S586fs mutations did not interact with lebercilin, as evidenced by
the fact that neither growth nor b-galactosidase activity could be detected in the assays.
(B) Liquid b-galactosidase assays revealed that the OFD1 p.K948fs mutation decreased the LacZ reporter gene activity to 24% as
compared to that of the wild-type (Student t test, p value ¼ 0.0005), indicating a signiﬁcant reduction in interaction with lebercilin.
The p.E923fs mutant retained only 18% of reporter gene activity (p value¼ 0.0003). For the p.E709fs mutant, 60% of activity remained;
this activity level was not signiﬁcantly different from that of OFD1 wild-type at a p value threshold of 0.005 (p value ¼ 0.03). For the
calculation of relative remaining reporter gene activity, values were corrected for background activity in the assay. Error bars represent
the standard error of the mean.eCFP-OFD1. In contrast, the OFD1 syndrome-associated
p.N630fs and p.S586fs mutant proteins localized diffusely
throughout the cytoplasm and showed only a limited,
severely reduced concentration around the basal body
(Figures 6M–6R). The p.I784fs mutant protein, which is
also associated with OFD1 syndrome, showed comparable
scattering throughout the cytoplasm but showed clear
concentration at both centrioles (Figures 6G–6I). This local-
ization obviously differed from the pericentriolar localiza-The Amertion observed for wild-type OFD1 and for the XL-JS and
SGBS2-associated mutant proteins.
Discussion
Until now, Joubert syndrome has been recognized as an
autosomal-recessive disorder.51 In this study, we report
that in two unrelated families with X-linked recessive JSican Journal of Human Genetics 85, 465–481, October 9, 2009 475
(as deﬁned by the presence of the molar tooth sign), exon
21 of OFD1 contains two separate protein-truncating
mutations. The mutations cosegregated with the disease
and were not found in more than 250 controls. Affected
males primarily presented with mental retardation accom-
panied by postaxial polydactyly. Central apnea was noted
in at least one family member of the XL-JS family and in
isolated patient UW87. In the XL-JS family, early-onset
retinal degeneration was reported, showing that OFD1
mutations can cause classic JS with retinal involvement.3
The facial dysmorphism, oral anomalies, and overgrowth
in patient UW87 reveal phenotypic overlap between
OFD1-related JS, SGBS2, and OFD1 syndrome.
The OFD1 gene has previously been associated with
OFD1 syndrome,27 which is a male-lethal X-linked domi-
OFD1 S586fs GT 335 OFD1 S586fs
GT 335
OFD1 E709fs GT 335 OFD1 E709fs GT 335
M N O
A B C
OFD1 N630fs GT 335 OFD1 N630fs 
GT 335
GT 335
GT 335OFD1 K948fs OFD1 K948fs
OFD1 E923fs GT 335 OFD1 E923fs GT 335
J K L
D E F
OFD1 I784fs GT 335
GT 335
OFD1 I784fs 
G II
P Q R
H
Figure 6. Localization of OFD1 Mutants
upon Overexpression in hTERT-RPE1 Cells
(A–C) Colocalization of eCFP-OFD1
p.K948fs (A, green) with the basal body
and cilium marker GT335 (B, red). The
mutant protein shows pericentriolar local-
ization comparable to that observed for
wild-type eCFP-OFD1. (C) is an overlay of
(A) and (B).
(D–F) Colocalization of eCFP-OFD1
p.K923fs (D, green) with GT335 (E, red),
showing pericentriolar localization. (F) is
an overlay of (D) and (E).
(G–I) eCFP-OFD1 p.I784fs (G, green) is
scattered throughout the cytoplasm but
concentrates at both centrioles, which are
indicated by GT335 staining (H, red). (I)
is an overlay of (G) and (H).
(J–L) Colocalization of eCFP-OFD1
p.E709fs (J, green) with GT335 (K, red),
indicating pericentriolar localization. (L)
is an overlay of (J) and (K).
(M–O) eCFP-OFD1 p.N630fs (M, green)
localizes diffusely throughout the cyto-
plasm, and only limited colocalization
with GT335 (N, red) is observed. (O) is an
overlay of (M) and (N).
(P–R) eCFP-OFD1 p.S586fs (P, green) also
shows cytoplasmic distribution and
limited colocalizationwithGT335 (Q, red).
(R) is an overlay of (P) and (Q).
In all pictures, nuclei are stained with
DAPI (blue).
nant condition primarily involving
malformations of the face, oral cavity,
and digits (Table 2). Cystic kidney
disease is also commonly associated
with this disorder, as are central
nervous system abnormalities. How-
ever, a molar tooth sign on a brain
MRI has never been reported. OFD1
syndrome belongs to the broad spec-
trum of cilia-related disorders or cilio-
pathies; the OFD1 protein was found
to localize to centrosomes52 and basal
bodies in renal epithelial cells.46,53
Mice lacking Ofd1 reproduced the main features of the
human disease and showed several hallmarks of ciliary
dysfunction, such as failure of left-right axis speciﬁcation,
polydactyly, and renal cyst development.54 Mutations in
OFD1 have also been found in a single family presenting
with X-linked recessive mental retardation, macrocephaly,
and respiratory ciliary dyskinesia (SGBS2; Table 2).28 The
index patient in this study, who was the only living
affected individual in the family, showed no molar tooth
sign on a brain MRI. However, no brain-scan data were
available for the other, more severely affected patients,
who died soon after birth, so it can not be completely
excluded that SGBS2 belongs to the spectrum of JSRDs.
The two XL-JSRD mutations reported here lead to
a frameshift that results in a premature termination codon476 The American Journal of Human Genetics 85, 465–481, October 9, 2009
Table 2. Clinical Features of the XL-JS Family and Isolated JS Patient UW87 as Compared to SGBS2 and Females with OFD1 Syndrome
Clinical Symptom XL-JS XL-JS (UW87) SGBS228 OFD158
General
Inheritance recessive de novo recessive dominant
Recurrent infections þ - þ -
Juvenile RP þ - - -
Cystic kidneys - - - þ
Obesity - þ þ -
Typical age of male death >20 yrs >12 yrs <3yrs Prenatal
Neurological Findings
Mental retardation severe/profound severe severe mild
Hypotonia - þ þ -
Central apnea þ þ - -
Molar tooth sign þ þ - -
Corpus callosum agenesis - - - þ
Dysmorphisms
Macrocephaly - þ þ -
High-arched palate - - þ -
Low-set ears þ - þ -
Broad nasal bridge þ - - þ
Hypotelorism - - - þ
Hypoplasia of the nasal alae - þ/ - þ
Downslanting palpebral ﬁssures - - - þ
Oral Abnormalities
Cleft lip/palate - þ/** - þ
Tongue abnormalities - þ - þ
Abnormal dentition - - - þ
Digital Abnormalities
(Postaxial) polydactyly þ þ þ þ*
Brachydactyly - þ þ þ
Clinodactyly - - - þ
Broad thumbs - þ/ þ -
Long digits þ - - -
* Postaxial polydactyly has been reported in OFD1 syndrome but occurs rarely (<5%).
** Notched lip.in the OFD1mRNA; this in turn renders the mutant mRNA
subject to nonsense-mediated decay. Consequently, only
about 30%–60% of OFD1 transcript persists. This is also
the case for the SGBS2 mutation (Figure S1). Most OFD1-
syndrome-associated mutations also result in premature
termination codons and are thus predicted to reduce tran-
script levels as well. Therefore, we postulate that the
phenotypic variability observed for OFD1 mutations is
primarily caused by changes in activity of the remaining
truncated OFD1 protein (Figure 7). Overall, the severityThe Amerof the phenotype correlates with a reduction in OFD1
protein length. All mutations before amino acid residue
631 are lethal for males and cause OFD1 syndrome in
females. The SGBS2-associated p.E709fs mutation causes
macroencephaly and early death inmales because of severe
respiratory-tract infections, but it leaves females unaf-
fected. Male patients with the p.K948fs and p.E923fs muta-
tions, which are located in the coiled-coil domain nearest
to the C-terminal end of the protein, have JS and may
live beyond the age of 30 years, whereas carrier femalesican Journal of Human Genetics 85, 465–481, October 9, 2009 477
are not affected. Interestingly, two exon 17 mutations that
are positioned between the SGBS2 and the XL-JS muta-
tions have been described49,55: one is a frameshift
(p.I784fs), and one is a deletion of the complete exon.
These exon 17 mutations are lethal to males and cause
OFD1 syndrome in females. This shows that the pheno-
typic boundaries are variable and that other factors, such
as variable degrees of RNA degradation, contribute to the
differences in phenotype as well.
We show that OFD1 physically interacts with lebercilin,
the protein encoded by the LCA-associated gene LCA5.29
The functional signiﬁcance of this interaction is stressed
by the fact that the X-linked JS family we report here also
suffers from retinal degeneration. For the family members
IV-5 and IV-6, as well as for isolated patient UW87, no
retinal phenotype could be diagnosed. However, moni-
toring of these patients is advisable because a retinal
pathology could develop in the future. Variability in the
onset and severity of the retinal phenotype among and
within families is a common feature with isolated RP and
even more so in (retinal) ciliopathies, which often express
a variable combination of phenotypes.9 Furthermore, we
show that OFD1 is present in retinal photoreceptor cells,
where it colocalizes with lebercilin in the transition zone
of the photoreceptor sensory cilium. In other cell types,
both OFD1 and lebercilin localize to the basal body and/
or to primary cilia.29,46,52 Our interaction data show that
the p.K948fs, p.E923fs, and p.E709fs mutations in OFD1
weakened the interaction with lebercilin but did not
16 21OFD1 2
Gender Phenotype
lethal
SGBS2
XL-JS
None
None
OFD1
p.E923fs
p.K948fsp.I784fs 
p.E709fs 
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p.S586fs 
Figure 7. Genotype-Phenotype Correlation of OFD1 Mutations
with OFD1, SGBS2, and XL-JS
Mutations thus far reported as occurring before amino acid residue
631 are all embryonic lethal for males. In females, these cause
OFD1 syndrome. The SGBS2-associated p.E709fs mutation causes
early death in males, but females are not affected. Male patients
with the p.E923fs and p.K948fs mutations that cause XL-JS may
live beyond the age of 30 years. We have also indicated the
position of the exon 17 p.I784fs mutation that results in OFD1
syndrome in females and is lethal to males to show that the
phenotype boundaries are variable (dotted lines). However,
the overall severity of the phenotype inversely correlates with
the size of the remaining OFD1 protein.478 The American Journal of Human Genetics 85, 465–481, Octobetotally disrupt it. OFD1-eCFP fusion proteins containing
the p.K948fs, p.E923fs, and p.E709fs mutations showed
normal pericentriolar localization in hTERT-RPE1 cells.
In contrast, the male-lethal dominant OFD1 p.I784fs,
p.N630fs, and p.S586fs mutations completely abolished
interactionwith lebercilin, and upon expression of the cor-
responding mutated recombinant proteins in hTERT-RPE1
cells, pericentriolar localization was lost completely;
however, apart from diffuse cytoplasmic localization, the
p.I784fs mutant protein showed concentration at both
centrioles, and such an observation was not made for the
p.N630fs and p.S586fs mutant proteins. The p.I784fs
mutation lies in exon 17, which is further downstream
than the p.N630fs and p.S586fs mutations and results in
a longer remaining mutant protein. This mutant protein
might retain the ability to concentrate at the centrioles,
but it has lost pericentriolar localization as well as leberci-
lin binding afﬁnity. Taken together, these data support the
hypothesis that differences in binding afﬁnity of the OFD1
mutant protein to functionally interacting proteins, such
as lebercilin, underlie the phenotypic variability observed
for OFD1 syndrome, SGBS2, and XL-JS.
The exact cellular function ofOFD1 is not knownyet, but
evidence from studies with knock-out mice shows that
OFD1 is required for primary cilia formation and left-right
axis speciﬁcation.54 In limb buds of these mice, which
consistently showed polydactyly, altered expression of
Hoxa and Hoxd genes was observed. These genes regulate
limb patterning downstream of Gli3, which is a transcrip-
tion factor in the Shh pathway.56 Although Gli3 itself and
other players in the Shh pathway showed no altered gene
expression in the limb buds of Ofd1-null mice, OFD1
disruption could affect Gli3 function, whichwould explain
the upregulation of Hox genes. In this line of thinking, it is
interesting to note that Ofd1 knock-out mice show overall
phenotypic overlap with RPGRIP1L-null mice.20,26 Studies
in RPGRIP1L/Ftm-nullmice identiﬁed RPGRIP1L as a neces-
sary component for cilium-mediated Shh signaling.26 It is
tempting to speculate that OFD1 might also be involved
in this pathway; such involvement would explain the
occurrence of polydactyly in patients with OFD1 muta-
tions. Furthermore, mutations in the JS gene Arl13b were
identiﬁed as underlying the lethal hennin mouse mutant
that shows disruption of the ciliary axoneme and displays
a Shh-like phenotype, including defective neural-tube
patterning and polydactyly.15 These studies suggest that
cilium-mediated regulation of Shh signaling might be
a commonly disrupted pathway in JS.
In conclusion, we have identiﬁed OFD1 as a JSRD gene
and have expanded the recognized inheritance pattern of
JSRDs to include X-linked recessive. Mutations in OFD1
are now known to be associated with three disorders:
OFD1 syndrome, SGBS2, and XL-JS. We propose that the
inverse correlation between OFD1 mutant protein length
and phenotypic severity could be explained by differences
in binding to functionally interacting proteins and disrup-
tion of ciliary localization.r 9, 2009
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